We are live on ! Find out more
TCM

Tanaka Capital Management Portfolio holdings

AUM $59.9M
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$44.9M
AUM Growth
+$1.21M
Cap. Flow
+$56K
Cap. Flow %
0.12%
Top 10 Hldgs %
63.21%
Holding
54
New
1
Increased
12
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$701K
2
PARAA
Paramount Global Class A
PARAA
+$334K
3
AAPL icon
Apple
AAPL
+$300K
4
PEP icon
PepsiCo
PEP
+$135K
5
BYSI icon
BeyondSpring
BYSI
+$55.8K

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$1.04M
2
INO icon
Inovio Pharmaceuticals
INO
+$688K
3
ADXS
Advaxis Inc
ADXS
+$475K
4
TSEM icon
Tower Semiconductor
TSEM
+$436K
5
SF
Stifel
SF
+$149K

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 21.79%
3 Miscellaneous 10.72%
4 Energy 8.7%
5 Communication Services 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSEM icon
1
Tower Semiconductor
TSEM
$25.1B
$4.99M 11.12%
162,199
-15,987
-9% -$436K
NXE icon
2
NexGen Energy
NXE
$7.19B
$3.88M 8.65%
1,747,531
-55,201
-3% -$129K
AAPL icon
3
Apple
AAPL
$4.67T
$3.53M 7.88%
91,700
+7,732
+9% +$300K
IONS icon
4
Ionis Pharmaceuticals
IONS
$9.65B
$3.15M 7.02%
62,101
-19,836
-24% -$1.04M
PARAA
5
DELISTED
Paramount Global Class A
PARAA
$2.91M 6.49%
50,199
+5,228
+12% +$334K
CORT icon
6
Corcept Therapeutics
CORT
$12.1B
$2.7M 6.02%
139,867
+470
+0.3% +$7.01K
CELG
7
DELISTED
Celgene Corp
CELG
$2.06M 4.59%
14,105
+160
+1% +$21.8K
RTEC
8
DELISTED
Rudolph Technologies Inc
RTEC
$1.83M 4.08%
69,555
-1,422
-2% -$33.3K
AMRS
9
DELISTED
Amyris Inc.
AMRS
$1.69M 3.77%
528,549
+221,295
+72% +$701K
TSLA icon
10
Tesla
TSLA
$1.4T
$1.56M 3.48%
68,610
-90
-0.1% -$2.08K
ALK icon
11
Alaska Air
ALK
$4.69B
$1.51M 3.38%
19,855
+23
+0.1% +$1.88K
AFL icon
12
Aflac
AFL
$58.8B
$1.37M 3.06%
33,728
+626
+2% +$25.2K
HON icon
13
Honeywell
HON
$66.4B
$888K 1.98%
6,936
– –
ONTO icon
14
Onto Innovation
ONTO
$13.2B
$845K 1.88%
29,349
+1,170
+4% +$30.8K
JBLU icon
15
JetBlue
JBLU
$1.75B
$842K 1.88%
45,414
-350
-0.8% -$7.34K
BYSI icon
16
BeyondSpring
BYSI
$25.4M
$838K 1.87%
22,742
+1,420
+7% +$55.8K
HELE icon
17
Helen of Troy
HELE
$661M
$730K 1.63%
7,536
-36
-0.5% -$3.46K
QCOM icon
18
Qualcomm
QCOM
$180B
$692K 1.54%
13,345
-2,754
-17% -$146K
PM icon
19
Philip Morris
PM
$284B
$616K 1.37%
5,545
-45
-0.8% -$5.24K
CPRX
20
DELISTED
Catalyst Pharmaceutical
CPRX
$608K 1.36%
241,078
– –
SF
21
Stifel
SF
$12.3B
$565K 1.26%
23,783
-6,873
-22% -$149K
NTRP
22
DELISTED
Neurotrope, Inc. Common
NTRP
$416K 0.93%
80,705
– –
PEP icon
23
PepsiCo
PEP
$188B
$385K 0.86%
3,457
+1,165
+51% +$135K
GOOG icon
24
Alphabet (Google) Class C
GOOG
$4.1T
$340K 0.76%
7,040
– –
NFLX icon
25
Netflix
NFLX
$326B
$197K 0.44%
10,850
– –
1
2

Similar funds

GC
Greencape Capital Melbourne, Australia $59.9M AUM 23.92% 1-Year Est. Return
ACM
AREX Capital Management New York $60.5M AUM 45.91% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
IPHI
Inflection Point Holdings II New York $47.3M AUM
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Tanaka Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Tanaka Capital Management held 54 positions worth $44.9M, up 2.8% from $43.6M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tanaka Capital Management's Q3 2017 filing shows 1 new, 12 increased, 12 reduced and 4 closed positions. The largest sale was Ionis Pharmaceuticals, an estimated $1.04M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Tanaka Capital Management added most to Amyris Inc. in Q3 2017, an estimated $701K increase.
  • Tanaka Capital Management's biggest Q3 2017 reduction was Ionis Pharmaceuticals, cutting an estimated $1.04M.
  • Tanaka Capital Management fully exited Inovio Pharmaceuticals in Q3 2017, selling an estimated $688K.
  • Tanaka Capital Management's ten largest holdings make up 63% of its $44.9M portfolio in Q3 2017.
  • Tanaka Capital Management opened 1 new position and closed 4 in Q3 2017.
  • Tanaka Capital Management's portfolio value rose 2.8% quarter-over-quarter to $44.9M.

Based on Tanaka Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.